Training on in silico host-tissue mixtures reduces host attraction in RNA-seq-based tissue-of-origin classification of metastatic biopsies

Background Transcriptome classifiers that infer the primary site of metastases are trained mostly on primary tumors, but metastatic biopsies also contain normal host-organ cells. Such classifiers can name the biopsied organ instead of the primary, an error we call host attraction. A previous method reduced errors in liver metastases by training a microRNA classifier on in silico tumor–liver mixtures. Using internally preregistered analyses, we tested whether mixtures with several host tissues reduce host attraction in a whole-transcriptome classifier. Results We trained logistic regression classifiers for 32 tumor types with or without in silico tumor–normal mixtures from ten host tissues (HostMix-TOO). In POG570, HostMix-TOO reduced host attraction from 22.8% to 2.4% of at-risk biopsies (n = 378; −20.4 percentage points, 95% CI − 24.3 to − 16.4) and increased top-1 accuracy from 68.2% to 75.6% (n = 512; 7.4 points, 95% CI 3.9 to 10.7). Non-inferiority of accuracy for biopsies from the organ of origin was not shown (86.8% versus 80.2%, n = 91; one-sided 95% lower bound − 12.1 points, margin − 10). In six auxiliary RNA-seq cohorts, all three primary hypotheses were confirmed: host attraction fell from 20.4% to 5.6% (n = 427), top-1 accuracy rose from 52.7% to 69.8% (n = 729), mostly in one bladder cancer cohort, and accuracy for biopsies from the organ of origin was non-inferior (n = 315). Published classifiers SCOPE and CUP-AI-Dx showed host attraction in 12.2–30.4% of at-risk biopsies (HostMix-TOO: 2.4–5.6%), although CUP-AI-Dx was more accurate in auxiliary cohorts. In five microarray cohorts, HostMix-TOO reduced host attraction but lowered top-1 accuracy from 72.4% to 45.5% (n = 536). A post hoc ablation attributed the host-attraction reduction to the mixtures and the microarray loss to feature standardization: without standardization, mixtures reduced microarray host attraction from 25.6% to 9.2% (n = 207) with 77.6% top-1 accuracy. Conclusions For RNA-seq biopsies, training on in silico host-tissue mixtures reduced host attraction and improved accuracy in two preregistered evaluations. Post hoc analyses traced the microarray loss to feature standardization, which requires confirmation. Benchmarks of tissue-of-origin classifiers on metastatic biopsies should report host attraction, with its denominator, alongside top-1 accuracy.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11293314/v1
Primary Topic
Gene expression and cancer classification
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Training on in silico host-tissue mixtures reduces host attraction in RNA-seq-based tissue-of-origin classification of metastatic biopsies

Juwon Kang, Junjeong Choi
Research Square
Gene expression and cancer classification
preprint

Training on in silico host-tissue mixtures reduces host attraction in RNA-seq-based tissue-of-origin classification of metastatic biopsies

Juwon Kang, Junjeong Choi
preprint en

Abstract

Background Transcriptome classifiers that infer the primary site of metastases are trained mostly on primary tumors, but metastatic biopsies also contain normal host-organ cells. Such classifiers can name the biopsied organ instead of the primary, an error we call host attraction. A previous method reduced errors in liver metastases by training a microRNA classifier on in silico tumor–liver mixtures. Using internally preregistered analyses, we tested whether mixtures with several host tissues reduce host attraction in a whole-transcriptome classifier. Results We trained logistic regression classifiers for 32 tumor types with or without in silico tumor–normal mixtures from ten host tissues (HostMix-TOO). In POG570, HostMix-TOO reduced host attraction from 22.8% to 2.4% of at-risk biopsies (n = 378; −20.4 percentage points, 95% CI − 24.3 to − 16.4) and increased top-1 accuracy from 68.2% to 75.6% (n = 512; 7.4 points, 95% CI 3.9 to 10.7). Non-inferiority of accuracy for biopsies from the organ of origin was not shown (86.8% versus 80.2%, n = 91; one-sided 95% lower bound − 12.1 points, margin − 10). In six auxiliary RNA-seq cohorts, all three primary hypotheses were confirmed: host attraction fell from 20.4% to 5.6% (n = 427), top-1 accuracy rose from 52.7% to 69.8% (n = 729), mostly in one bladder cancer cohort, and accuracy for biopsies from the organ of origin was non-inferior (n = 315). Published classifiers SCOPE and CUP-AI-Dx showed host attraction in 12.2–30.4% of at-risk biopsies (HostMix-TOO: 2.4–5.6%), although CUP-AI-Dx was more accurate in auxiliary cohorts. In five microarray cohorts, HostMix-TOO reduced host attraction but lowered top-1 accuracy from 72.4% to 45.5% (n = 536). A post hoc ablation attributed the host-attraction reduction to the mixtures and the microarray loss to feature standardization: without standardization, mixtures reduced microarray host attraction from 25.6% to 9.2% (n = 207) with 77.6% top-1 accuracy. Conclusions For RNA-seq biopsies, training on in silico host-tissue mixtures reduced host attraction and improved accuracy in two preregistered evaluations. Post hoc analyses traced the microarray loss to feature standardization, which requires confirmation. Benchmarks of tissue-of-origin classifiers on metastatic biopsies should report host attraction, with its denominator, alongside top-1 accuracy.

Research Square
Yonsei University (KR)
Gene expression and cancer classification
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon